BEAM
Price
$23.44
Change
+$0.04 (+0.17%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
1.94B
46 days until earnings call
MDGL
Price
$293.36
Change
+$20.57 (+7.54%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
5.95B
40 days until earnings call
Ad is loading...

BEAM vs MDGL

Header iconBEAM vs MDGL Comparison
Open Charts BEAM vs MDGLBanner chart's image
Beam Therapeutics
Price$23.44
Change+$0.04 (+0.17%)
Volume$15.99K
Capitalization1.94B
Madrigal Pharmaceuticals
Price$293.36
Change+$20.57 (+7.54%)
Volume$16.22K
Capitalization5.95B
BEAM vs MDGL Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. MDGL commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and MDGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (BEAM: $23.40 vs. MDGL: $272.79)
Brand notoriety: BEAM and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 75% vs. MDGL: 101%
Market capitalization -- BEAM: $1.94B vs. MDGL: $5.95B
BEAM [@Biotechnology] is valued at $1.94B. MDGL’s [@Biotechnology] market capitalization is $5.95B. The market cap for tickers in the [@Biotechnology] industry ranges from $370.67B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 1 green, 4 red.
According to our system of comparison, MDGL is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while MDGL’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 6 bearish.
  • MDGL’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than MDGL.

Price Growth

BEAM (@Biotechnology) experienced а -12.69% price change this week, while MDGL (@Biotechnology) price change was -18.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

MDGL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($5.95B) has a higher market cap than BEAM($1.94B). BEAM YTD gains are higher at: -5.645 vs. MDGL (-11.595). BEAM has higher annual earnings (EBITDA): -160.83M vs. MDGL (-502.65M). MDGL has more cash in the bank: 999M vs. BEAM (926M). MDGL has less debt than BEAM: MDGL (119M) vs BEAM (162M). BEAM has higher revenues than MDGL: BEAM (350M) vs MDGL (76.8M).
BEAMMDGLBEAM / MDGL
Capitalization1.94B5.95B33%
EBITDA-160.83M-502.65M32%
Gain YTD-5.645-11.59549%
P/E RatioN/AN/A-
Revenue350M76.8M456%
Total Cash926M999M93%
Total Debt162M119M136%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
33
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMMDGL
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
83%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
87%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.04%
CRSP - BEAM
70%
Closely correlated
+3.23%
NTLA - BEAM
62%
Loosely correlated
-2.99%
DNLI - BEAM
61%
Loosely correlated
+0.79%
PRME - BEAM
60%
Loosely correlated
+0.35%
RXRX - BEAM
59%
Loosely correlated
-0.31%
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with ETNB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
-0.59%
ETNB - MDGL
41%
Loosely correlated
-2.79%
CRSP - MDGL
36%
Loosely correlated
+3.23%
AKRO - MDGL
35%
Loosely correlated
+7.62%
BEAM - MDGL
32%
Poorly correlated
+0.04%
RIGL - MDGL
31%
Poorly correlated
-3.66%
More